Market Overview
Contusions develop when a blunt instrument strikes a region of the body directly or repeatedly, crushing underlying muscle fibers and connective tissue without breaking the skin. Falling or slamming the body against a hard surface can cause a contusion. A bone contusion (bruise) or even a fracture may occur due to the muscle contusion (broken bone). Contusions get better quickly with simple treatment measures such as pain relief medications.
The global muscle contusion market size was valued US$ XX million in 2020 and is estimated to reach US$ XX million by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).
Market Dynamics
Increasing product launches by the key players are expected to drive market growth.
The U.S. Food and Drug Administration (FDA) approved Zynrelef (extended-release dual-acting local anesthetic of bupivacaine and meloxicam) for pain treatment in May 2021, according to Heron Therapeutics, Inc. Moreover, The United States Food and Drug Administration granted Strides Pharma Science Limited approval for Ibuprofen Oral Suspension in February 2021. (USFDA). Therefore, the market is expected to drive in the forecast period.
Restraint:
Medications are a mainstay of treatment in the injured athletes for their pain relief and healing properties. As these drugs have potential healing benefits, it also has common side effects. For instance, Narcotic Analgesics, Drowsiness and impaired judgment often occur with these medicines, constipation, nausea, or vomiting. Moreover, withdrawal symptoms are common when a patient stops taking a narcotic. Symptoms include a strong desire for the medicine (craving), yawning, insomnia, restlessness, mood swings, or diarrhea. Therefore, above are some of the factors the market is expected to get hampered in the forecast period.
COVID-19 Impact Analysis
The current COVID-19 pandemic led elite athletes from various sports to cancel events and training sessions, which lasted eight weeks in several countries (Italy, Spain, and others). Long-term detraining, such as the COVID-19 forced stop, is well documented to result in a significant decrease in maximal oxygen consumption (VO2max), the loss of previously gained increases in endurance capacity, and, most critically, a loss of muscular strength and mass. The muscular-tendon issue casts serious doubt on a quick return to professional competition. Athletes lose muscular mass, strength, and power after eight weeks of detraining due to decreasing electromyographic activity (EMG), which reduces muscle activation. In both non-contact and contact sports like soccer, such a decrease in skeletal muscle activity could significantly increase the risk of injury. Moreover, the consistent virus spread has significantly obstructed the supply chain of the muscle contusion market. Thus, the market will undergo impetus during the forecast period.
Segment Analysis
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) segment is expected to hold the largest market share in muscle contusion market.
The nonsteroidal anti-inflammatory drugs segment accounted for the largest market share in 2020. Muscle injuries are a broad term that encompasses a variety of diseases, and they are common among top and amateur athletes and the general public. Skeletal muscle injuries account for a significant part of all sports medicine injuries, accounting for 10% to 55% of all sustained injuries. The muscles and muscle groups most commonly involved are the hamstrings, rectus femoris, and medial head of the gastrocnemius. For muscular injury, most doctors prefer nonsteroidal anti-inflammatory medications (NSAIDs). Nonsteroidal anti-inflammatory medications (NSAIDs) are a type of medication that relieves pain, lowers fever, avoids blood clots, and reduces inflammation in larger doses. Non-selective NSAIDs and COX-2 selective NSAIDs are also available. The majority of NSAIDs are non-selective, inhibiting both COX-1 and COX-2 activity. Aspirin, ibuprofen, and naproxen are the most common NSAIDs, all of which are accessible over-the-counter (OTC) in most countries. For instance, ibuprofen, known under brand names such as Advil and Motrin, is one of several drugs in a family called nonsteroidal anti-inflammatory drugs (NSAIDs), most commonly used to treat mild to moderate muscle pain. Therefore, muscle injury has increased the demand for nonsteroidal anti-inflammatory drugs (NSAIDs). Thus, the market segment is expected to hold the largest market share in the forecast period.
Geographical Analysis
North America region holds the largest market share in the global muscle contusion market
In 2020, North America accounted for the highest revenue share. Increasing prevalence of sports injuries, rising cases of trauma, product launches by the key players, well-established healthcare facilities in the region are a few factors that the market is expected to boost in the forecast period. For instance, injuries can occur in any sport, whether from the trauma of contact with other players or from overuse or misuse of a body part. According to the National Safety Council (NSC), in 2020, bicycling accounted for about 426,000 injuries, most of any sports and recreation category. With or without equipment, exercise followed with about 378,000 injuries, while ATV, moped and minibike use with 230,000 injuries, and skateboard, scooter and hoverboard use, with 218,00 injuries, ranked third and fourth.
Moreover, the concern is growing about the risks of sports-related concussions such as football can be expected to result in a higher number of injuries than a noncontact sport such as swimming. The problem also affects thousands of young people who engage in various sports. According to the NSC, being struck by another person or object is the leading cause of unintentional injury for teens and young adults ages 15 to 24. Therefore, from the above statements, the North American region is expected to hold the largest market share in the forecast period.
Competitive Landscape
Major key players in the muscle contusion market are Johnson & Johnson Consumer Inc., Pfizer Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Bayer AG , Taro Pharmaceuticals U.S.A., Inc., Sanofi, Horizon Therapeutics plc, AstraZeneca and Assertio Holdings, Inc.
Johnson &Johnson Inc.:
Overview:
Johnson &Johnson is an American multinational corporation. The company is into medical devices, pharmaceuticals, and consumer packaged goods. Johnson & Johnson's brands include more household names of medications and first aid supplies. Its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnsons Baby products, Neutrogena skin and beauty products, Clean &Clear facial wash, and Acuvue contact lenses. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceutical.
Product Portfolio:
Tylenol: Pain accompanying minor acute soft-tissue injuries may be relieved by a short course of nonnarcotic analgesics with acetaminophen (Tylenol)
Why Purchase the Report?
- Visualize the composition of the global muscle contusion market segmentation by drug type, distribution channel and region highlighting the key commercial assets and players.
- Identify commercial opportunities in global muscle contusion market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of global muscle contusion market- level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key product of all major market players
The global muscle contusion market report would provide an access to an approx.45+ market data table, 40+ figures and 180 pages.
Target Audience
- Service Providers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
- Manufacturers
Market Segmentation
Global Muscle Contusion Market - By Drug type
Acetaminophen (Tylenol, Feverall, Aspirin Free Anacin)
Others
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Indomethacin (Indocin)
Ketorolac (Toradol)
Ibuprofen (Motrin, Advil, Nuprin)
Others
Hydrocodone and acetaminophen (Vicodin, Lorcet, Lortab, Anexsia)
Oxycodone and acetaminophen (Percocet, Tylox, Roxicet)
Acetaminophen and codeine
Others
Global Muscle Contusion Market - By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Global Muscle Contusion Market - By Region
- North America
- South America
- Europe
- Asia Pacific
- Middle East & Africa
Table of Contents
1. Global Muscle Contusion Market - Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
2. Global Muscle Contusion Market - Market Definition and Overview
3. Global Muscle Contusion Market - Executive Summary
- 3.1. Market Snippet by Drug type
- 3.2. Market Snippet by Distribution Channel
- 3.3. Market Snippet by Region
4. Global Muscle Contusion Market - Market Dynamics
- 4.1. Market Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Increasing product launches by the key players are expected to drive market growth.
- 4.1.2. Restraints:
- 4.1.3. Side effects from the drugs are expected to hamper the market in the forecast period.
- 4.1.4. Opportunity
- 4.1.5. Impact Analysis
5. Global Muscle Contusion Market - Industry Analysis
- 5.1. Porter's Five Forces Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Regulatory Analysis
- 5.5. Reimbursement Analysis
- 5.6. Unmet Needs
6. Global Muscle Contusion Market - COVID-19 Analysis
- 6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
- 6.2. Pricing Dynamics Amid Covid-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
- 6.7. Others
7. Global Muscle Contusion Market - By Drug type
- 7.1. Introduction
- 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type
- 7.1.2. Market Attractiveness Index, By Drug type Segment
- 7.2. Nonnarcotic Analgesics
- 7.2.1. Acetaminophen (Tylenol, Feverall, Aspirin Free Anacin)
- 7.2.2. Others
- 7.2.3. Introduction
- 7.2.4. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
- 7.3. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- 7.3.1. Indomethacin (Indocin)
- 7.3.2. Ketorolac (Toradol)
- 7.3.3. Ibuprofen (Motrin, Advil, Nuprin)
- 7.3.4. Others
- 7.4. Narcotic Analgesics
- 7.4.1. Hydrocodone and acetaminophen (Vicodin, Lorcet, Lortab, Anexsia)
- 7.4.2. Oxycodone and acetaminophen (Percocet, Tylox, Roxicet)
- 7.4.3. Acetaminophen and codeine
- 7.4.4. Others
8. Global Muscle Contusion Market - By Distribution Channel
- 8.1. Introduction
- 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 8.1.2. Market Attractiveness Index, By Distribution Channel Segment
- 8.2. Hospital Pharmacies*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
- 8.3. Retail Pharmacies
- 8.4. Online Pharmacies
- 8.5. Others
9. Global Muscle Contusion Market - By Region
- 9.1. Introduction
- 9.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
- 9.1.2. Market Attractiveness Index, By Region
- 9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type
- 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 9.2.5.1. U.S.
- 9.2.5.2. Canada
- 9.2.5.3. Mexico
- 9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type
- 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 9.3.5.1. Germany
- 9.3.5.2. U.K.
- 9.3.5.3. France
- 9.3.5.4. Italy
- 9.3.5.5. Spain
- 9.3.5.6. Rest of Europe
- 9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type
- 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 9.4.5.1. Brazil
- 9.4.5.2. Argentina
- 9.4.5.3. Rest of South America
- 9.5. Asia Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type
- 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 9.5.5.1. China
- 9.5.5.2. India
- 9.5.5.3. Japan
- 9.5.5.4. Australia
- 9.5.5.5. Rest of Asia Pacific
- 9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type
- 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
10. Global Muscle Contusion Market - Competitive Landscape
- 10.1. Key Developments and Strategies
- 10.2. Company Share Analysis
- 10.3. Product Benchmarking
- 10.4. List of Key Companies to Watch
- 10.5. List of Company with disruptive technology
11. Global Muscle Contusion Market- Company Profiles
- 11.1. Johnson & Johnson Consumer Inc.*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Key Highlights
- 11.1.4. Financial Overview
- 11.2. Pfizer Inc.
- 11.3. GlaxoSmithKline plc
- 11.4. Boehringer Ingelheim International GmbH
- 11.5. Bayer AG
- 11.6. Taro Pharmaceuticals U.S.A., Inc.
- 11.7. Sanofi
- 11.8. Horizon Therapeutics plc
- 11.9. AstraZeneca
- 11.10. Assertio Holdings, Inc
LIST NOT EXHAUSTIVE
12. Global Muscle Contusion Market - DataM
- 12.1. Appendix
- 12.2. About Us
- 12.3. Contact Us
